SK Bioscience Co (XKRX:302440) EV-to-Revenue : 7.39 (As of Jun. 04, 2025)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SK Bioscience Co's enterprise value is ₩2,954,972 Mil. SK Bioscience Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₩399,832 Mil. Therefore, SK Bioscience Co's EV-to-Revenue for today is 7.39.

The historical rank and industry rank for SK Bioscience Co's EV-to-Revenue or its related term are showing as below:

XKRX:302440' s EV-to-Revenue Range Over the Past 10 Years
Min: 5.41 Med: 10.26 Max: 58
Current: 7.39

During the past 7 years, the highest EV-to-Revenue of SK Bioscience Co was 58.00. The lowest was 5.41. And the median was 10.26.

XKRX:302440's EV-to-Revenue is ranked worse than
50.1% of 996 companies
in the Biotechnology industry
Industry Median: 7.385 vs XKRX:302440: 7.39

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-04), SK Bioscience Co's stock price is ₩46150.00. SK Bioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩5,114.17. Therefore, SK Bioscience Co's PS Ratio for today is 9.02.

SK Bioscience Co EV-to-Revenue Historical Data

The historical data trend for SK Bioscience Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co EV-to-Revenue Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

16.87

9.36

11.58

12.43

SK Bioscience Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															9.58	7.87	15.51	12.43	6.16

Competitive Comparison of SK Bioscience Co's EV-to-Revenue

For the Biotechnology subindustry, SK Bioscience Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SK Bioscience Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SK Bioscience Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where SK Bioscience Co's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

SK Bioscience Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

SK Bioscience Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	2954971.836	/	399832.087
	=	7.39

SK Bioscience Co's current Enterprise Value is ₩2,954,972 Mil.
SK Bioscience Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩399,832 Mil.

SK Bioscience Co (XKRX:302440) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

SK Bioscience Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	46150.00	/	5114.172
	=	9.02

SK Bioscience Co's share price for today is ₩46150.00.
SK Bioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,114.17.

SK Bioscience Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co Headlines

No Headlines